Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 1 Prostatic Hyperplasia 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Carboplatin 159 Paclitaxel 153 Bevacizumab 85 Taxes 48 Gemcitabine 48 liposomal doxorubicin 47 Topotecan 41 Cisplatin 35 pembrolizumab 33 Cyclophosphamide 28 olaparib 25 Immunoglobulin G 24 Disulfides 24 Specimen Handling 21 Drug Therapy 20 Docetaxel 20 niraparib 18 Magnetic Resonance Spectroscopy 18 Doxorubicin 17 Biopsy 15 mirvetuximab soravtansine 14 Hyperthermic Intraperitoneal Chemotherapy 14 rucaparib 13 Nivolumab 12 Cytoreduction Surgical Procedures 11 Chemotherapy, Adjuvant 10 Albumin-Bound Paclitaxel 10 veliparib 9 Platinum 9 Neoadjuvant Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × TroVax × Clear all

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡